Inhibition of HBV replication by theophylline

Antiviral Research

Volumn 89, Issue 2, 2011, Pages 149-155

  Zheng, Zirui ^a,e   Li, Junyan ^c   Sun, Jing ^d   Song, Ting ^a   Wei, Congwen ^a   Zhang, Yanhong ^a   Rao, Guirong ^b   Chen, Guangming ^b   Li, DeChao ^c   Yang, Gongming ^d   Han, Bao ^d   Wei, Shi ^e   Cao, Cheng ^a   Zhong, Hui ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b No 458 Hospital of PLA   (China)

^c JIAMUSI UNIVERSITY   (China)

^d Beijing Public Security Hospital 100121   (China)

^e JILIN UNIVERSITY   (China)

Author keywords

DNA damage signaling pathway; HBV transgenic mice; Theophylline

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; THEOPHYLLINE; VIRUS DNA; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DISEASE MODELS, ANIMAL; DNA, VIRAL; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; THEOPHYLLINE; TREATMENT OUTCOME; VIRAL LOAD; VIRUS REPLICATION;

ATAXIA TELANGIECTASIA; HEPATITIS B VIRUS; MUS MUSCULUS;

EID: 78751616582     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.12.004     Document Type: Article

References (25)

1. Bakkenist C.J., Kastan M.B. Initiating cellular stress responses. Cell 2004, 118:9-17.
2. Beasley R.P., Hwang L.Y. Overview on the epidemiology of hepatocellular carcinoma. Viral Hepatitis and Liver Disease. 1991, 532-535. Williams and Willkins, Baltimore. F.B. Hollinger, S.M. Lemon, M. Margolis (Eds.).
3. Chou Y.C., Jeng K.S., Chen M.L., Liu H.H., Liu T.L., Chen Y.L., Liu Y.C., Hu C.P., Chang C. Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method. J. Virol. 2005, 79:1813-1823.
4. Daniel R., Kao G., Taganov K., Greger J.G., Favorova O., Merkel G., Yen T.J., Katz R.A., Skalka A.M. Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage response. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4778-4783.
5. Gao L.F., Sun W.S., Ma C.H., Liu S.X., Wang X.Y., Zhang L.N., Cao Y.L., Zhu F.L., Liu Y.G. Establishment of mice model with human viral hepatitis B. World J. Gastroenterol. 2004, 10:841-846.
6. Gaspar M., Shenk T. Human cytomegalovirus inhibits a DNA damage response by mislocalizing checkpoint proteins. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2821-2826.
7. Kar P., Asim M., Sarma M.P., Patki P.S. HD-03/ES: a promising herbal drug for HBV antiviral therapy. Antiviral Res. 2009, 84:249-253.
8. Kudoh A., Fujita M., Zhang L., Shirata N., Daikoku T., Sugaya Y., Isomura H., Nishiyama Y., Tsurumi T. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J. Biol. Chem. 2005, 280:8156-8163.
9. Lau A., Swinbank K.M., Ahmed P.S., Taylor D.L., Jackson S.P., Smith G.C., O'Connor M.J. Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase. Nat. Cell. Biol. 2005, 7:493-500.
10. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 2004, 11:97-107.
11. Locarnini S. Molecular virology of hepatitis B virus. Semin. Liver Dis. 2004, 24(Suppl. 1):3-10.
12. Lee W.M. Hepatitis B virus infection. N. Engl. J. Med. 1997, 337:1733-1745.
13. Li D., Xu D.Z., Choi B.C., Men K., Zhang J.X., Lei X.Y., Yan Y.P. Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy. J. Med. Virol. 2005, 76:203-207.
14. Liu Y., Shevchenko A., Shevchenko A., Berk A.J. Adenovirus exploits the cellular aggresome response to accelerate inactivation of the MRN complex. J. Virol. 2005, 79:14004-14016.
15. Nunnari G., Argyris E., Fang J., Mehlman K.E., Pomerantz R.J., Daniel R. Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthines. Virology 2005, 335:177-184.
16. Roshal M., Kim B., Zhu Y., Nqhiem P., Planelles V. Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R. J. Biol. Chem. 2003, 278:25879-25886.
17. Sancar A., Lindsey-Boltz L.A., Unsal-Kaçmaz K., Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 2004, 73:39-85.
18. Sells M.A., Chen M.L., Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:1005-1009.
19. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 2003, 3:155-168.
20. Stracker T.H., Carson C.T., Weitzman M.D. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 2002, 418:348-352.
21. Wilkinson D.E., Weller S.K. Herpes simplex virus type I disrupts the ATR-dependent DNA-damage response during lytic infection. J. Cell. Sci. 2006, 119:2695-2703.
22. Wong S.N., Lok A.S. Update on viral hepatitis: 2005. Curr. Opin. Gastroenterol. 2006, 22:241-247.
23. Zhao F., Hou N.B., Song T., He X., Zheng Z.R., Ma Q.J., Li L., Zhang Y.H., Zhong H. Cellular DNA repair cofactors affecting hepatitis B virus infection and replication. World J. Gastroenterol. 2008, 14:5059-5065.
24. Zhao F., Hou N.B., Yang X.L., He X., Liu Y., Zhang Y.H., Wei C.W., Song T., Li L., Ma Q.J., Zhong H. Ataxia telangiectasia-mutated-Rad3-related DNA damage checkpoint signaling pathway triggered by hepatitis B virus infection. World J. Gastroenterol. 2008, 14:6163-6170.
25. Zimmerman E.S., Sherman M.P., Blackett J.L., Neidleman J.A., Kreis C., Mundt P., Williams S.A., Warmerdam M., Kahn J., Hecht F.M., Grant R.M., de Noronha C.M., Weyrich A.S., Greene W.C., Planelles V. Human immunodeficiency virus type 1 vpr induces DNA replication stress in vitro and in vivo. J. Virol. 2006, 80:10407-10418.